Your Location:Home >Products >small-molecule inhibitor >2621928-55-8
Purity:99%
KRASG12D, the most common oncogenic KRAS...
The present invention relates to compoun...
4-(4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-6-fluoro-5-((triisopropylsilyl)ethynyl)naphthalen-2-ol
4-(4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol
Conditions | Yield |
---|---|
With
cesium fluoride;
In
N,N-dimethyl-formamide;
at 20 ℃;
for 1h;
Inert atmosphere;
|
4.88 mg |
(1R,5S)-tert-butyl 3-(7-(8-ethynyl-7-fluoro-3-(methoxymethoxy)naphthalen-1-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
4-(4-((1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol
Conditions | Yield |
---|---|
With
hydrogenchloride;
In
1,4-dioxane; acetonitrile;
at 0 ℃;
for 1h;
Inert atmosphere;
|
56% |
((2-fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- yl)naphthalen-1-yl)ethynyl)triisopropylsilane
ethyl 2-oxopyrrolidine-5-carboxylate
ethyl 2-methylene-5-oxotetrahydro-1H-pyrrolizine-7a(5H)-carboxylate
ethyl 2,5-dioxotetrahydro-1H-pyrrolizine-7a(5H)-carboxylate
CAS:9003-63-8
CAS:52365-63-6
CAS:65896-14-2